Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Ehrenkranz

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
The Lancet. Global Health|September 21, 2023
Potential cost-effectiveness of community availability of tenofovir, lamivudine, and dolutegravir for HIV prevention and treatment in east, central, southern, and west Africa: a modelling analysisAndrew N Phillips, Loveleen Bansi-Matharu, Maryam Shahmanesh, et al.
The Lancet. HIV|October 24, 2025
Reducing HIV incidence and mortality: two sides of the same coin in the approach to ending AIDSJoseph N Jarvis, Peter Ehrenkranz, David S Lawrence, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 4, 2020
Patient-reported Reasons for Stopping Care or Switching Clinics in Zambia: A Multisite, Regionally Representative Estimate Using a Multistage Sampling-based Approach in ZambiaIzukanji Sikazwe, Ingrid Eshun-Wilson, Kombatende Sikombe, et al.
Plos One|February 25, 2016
Enrollment in HIV Care Two Years after HIV Diagnosis in the Kingdom of Swaziland: An Evaluation of a National Program of New Linkage ProceduresDuncan A MacKellar, Daniel Williams, Nosipho Storer, et al.
Plos Medicine|July 2, 2020
Participation in adherence clubs and on-time drug pickup among HIV-infected adults in Zambia: A matched-pair cluster randomized trialMonika Roy, Carolyn Bolton-Moore, Izukanji Sikazwe, et al.
Journal of the International AIDS Society|July 13, 2019
Optimizing responses to drug safety signals in pregnancy: the example of dolutegravir and neural tube defectsLynne M Mofenson, Anton L Pozniak, Jacque Wambui, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 26, 2019
Differentiated Care Preferences of Stable Patients on Antiretroviral Therapy in Zambia: A Discrete Choice ExperimentIngrid Eshun-Wilson, Mpande Mukumbwa-Mwenechanya, Hae-Young Kim, et al.
Plos Medicine|February 15, 2020
Emerging priorities for HIV service deliveryNathan Ford, Elvin Geng, Tom Ellman, et al.
BMC Medicine|November 9, 2020
Risk scores for predicting early antiretroviral therapy mortality in sub-Saharan Africa to inform who needs intensification of care: a derivation and external validation cohort studyAndrew F Auld, Katherine Fielding, Tefera Agizew, et al.
The Lancet. Global Health|September 24, 2020
Community-based antiretroviral therapy versus standard clinic-based services for HIV in South Africa and Uganda (DO ART): a randomised trialRuanne V Barnabas, Adam A Szpiro, Heidi van Rooyen, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
The Lancet. Global Health|September 21, 2023
Potential cost-effectiveness of community availability of tenofovir, lamivudine, and dolutegravir for HIV prevention and treatment in east, central, southern, and west Africa: a modelling analysisAndrew N Phillips, Loveleen Bansi-Matharu, Maryam Shahmanesh, et al.
The Lancet. HIV|October 24, 2025
Reducing HIV incidence and mortality: two sides of the same coin in the approach to ending AIDSJoseph N Jarvis, Peter Ehrenkranz, David S Lawrence, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 4, 2020
Patient-reported Reasons for Stopping Care or Switching Clinics in Zambia: A Multisite, Regionally Representative Estimate Using a Multistage Sampling-based Approach in ZambiaIzukanji Sikazwe, Ingrid Eshun-Wilson, Kombatende Sikombe, et al.
Plos One|February 25, 2016
Enrollment in HIV Care Two Years after HIV Diagnosis in the Kingdom of Swaziland: An Evaluation of a National Program of New Linkage ProceduresDuncan A MacKellar, Daniel Williams, Nosipho Storer, et al.
Plos Medicine|July 2, 2020
Participation in adherence clubs and on-time drug pickup among HIV-infected adults in Zambia: A matched-pair cluster randomized trialMonika Roy, Carolyn Bolton-Moore, Izukanji Sikazwe, et al.
Journal of the International AIDS Society|July 13, 2019
Optimizing responses to drug safety signals in pregnancy: the example of dolutegravir and neural tube defectsLynne M Mofenson, Anton L Pozniak, Jacque Wambui, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 26, 2019
Differentiated Care Preferences of Stable Patients on Antiretroviral Therapy in Zambia: A Discrete Choice ExperimentIngrid Eshun-Wilson, Mpande Mukumbwa-Mwenechanya, Hae-Young Kim, et al.
Plos Medicine|February 15, 2020
Emerging priorities for HIV service deliveryNathan Ford, Elvin Geng, Tom Ellman, et al.
BMC Medicine|November 9, 2020
Risk scores for predicting early antiretroviral therapy mortality in sub-Saharan Africa to inform who needs intensification of care: a derivation and external validation cohort studyAndrew F Auld, Katherine Fielding, Tefera Agizew, et al.
The Lancet. Global Health|September 24, 2020
Community-based antiretroviral therapy versus standard clinic-based services for HIV in South Africa and Uganda (DO ART): a randomised trialRuanne V Barnabas, Adam A Szpiro, Heidi van Rooyen, et al.
Pageof 5